Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model. (Q39175300)
Jump to navigation
Jump to search
scientific article published on 24 March 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model. |
scientific article published on 24 March 2013 |
Statements
Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model (English)
Fabia Febbraro
Kathrine J Andersen
Noemie Tentillier